Related Articles
Diallyl trisulfide reverses drug resistance and lowers the ratio of CD133+ cells in conjunction with methotrexate in a human osteosarcoma drug-resistant cell subline
Diallyl trisulfide exerts anti-inflammatory effects in lipopolysaccharide‑stimulated RAW 264.7 macrophages by suppressing the Toll‑like receptor 4/nuclear factor-κB pathway
Treatment of Saos‑2 osteosarcoma cells with diallyl trisulfide is associated with an increase in calreticulin expression
Diallyl trisulfide induces osteosarcoma cell apoptosis through reactive oxygen species-mediated downregulation of the PI3K/Akt pathway
Diallyl trisulfide induces apoptosis in human primary colorectal cancer cells